Considerations on how to apply these two general principles when conducting a risk assessment are included Module 3.

Annex III also contains a number of steps for conducting the risk assessment as well as points to consider on technical and scientific details regarding, for example, the characteristics of the genetic modification, biological characteristics of the LMO, differences between the LMO and its recipient organism, its intended use, the likely receiving environment, etc.

Module 3 of this training manual explains each of the steps of the risk assessment process according to Annex III of the Protocol.